Carfilzomib
Products in Health Canada’s databases that list Carfilzomib as a medicinal or active ingredient, under this spelling. The same substance can be listed under another name (a salt, a common name), which has its own page.
- Drug products
- 3
- 3 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 12
- Products in all
- 3
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| KYPROLIS (60 MG) | 02451034 | Marketed | Amgen Canada Inc | |
| KYPROLIS (10 MG) | 02459930 | Marketed | Amgen Canada Inc | |
| KYPROLIS (30 MG) | 02459949 | Marketed | Amgen Canada Inc |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- KYPROLISJuly 26, 2023 · NOC 31303
- KYPROLISJune 2, 2021 · NOC 25970
- KYPROLISJanuary 29, 2021 · NOC 25109
- KYPROLISFebruary 6, 2020 · NOC 23183
- KYPROLISSeptember 6, 2019 · NOC 22616
- KYPROLISJanuary 18, 2019 · NOC 21768
- KYPROLISOctober 25, 2018 · NOC 21459
- KYPROLISJune 8, 2018 · NOC 20960
- KYPROLISJuly 7, 2017 · NOC 19502
- KYPROLISDecember 20, 2016 · NOC 18796
- KYPROLISNovember 22, 2016 · NOC 18689
- KYPROLISJanuary 15, 2016 · NOC 17669